Jana Jakubikova

6PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Cellular immunologyAutoimmunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 17, 2026
Anti-myeloma activity of the CXCR4 antagonist WZ811.

Danka Cholujova, Nikoleta Csicsatkova, Zuzana Valuskova

|Dec 18, 2025
RVd and CyBorD therapies remodel B-cell maturation signaling and alter immune and clonal architecture in multiple myeloma.

Zuzana Valuskova, Dana Cholujova, Gabor Beke

|Oct 30, 2025
Altered Inhibitory Synaptic Transmission and Changes in GABAergic Markers in the Hippocampus of Genetic and Environmental Animal Model of Autism.

Bohumila Jurkovičová-Tarabová, Peter Vargovič, Denisa Mihalj

|Aug 18, 2025
CyTOF profiling of bone marrow immune dynamics across myeloma stages.

Dana Cholujova, Gabor Beke, Lubos Klucar

|Dec 19, 2022
Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia.

Danka Cholujova, Gabor Beke, Zachary R Hunter

|Oct 20, 2017
Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.

Danka Cholujova, Zdenka Bujnakova, Erika Dutkova

Pageof 1